欢迎来到天天文库
浏览记录
ID:208209
大小:43.00 KB
页数:5页
时间:2017-07-03
《V-HEFT I研究PPT课件.ppt》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库。
1、EffectofVasodilatorTherapyonMortalityinChronicCongestiveHeartFailureResultsofaVeteransAdministrationCooperativeStudy(V-HEFTI)Multicenter,randomized,double-blind,placebo-controlledtrial642menfollowedforanaverageof2.3yearsPatientHistory:Menwithimpaired
2、cardiacfunctionandreducedexercisetoleranceAllpatientsweretakingdigoxinanddiureticsInadditiontomortality,thefollow-updataincludedEF,exercisetoleranceandechocardiographyNEnglJMed1986;314:1547-52V-HEFTIObjectivesToevaluatetheeffectsofvasodilatortherapy
3、onmortalityamongpatientswithchroniccongestiveheartfailure,impairedcardiacfunctionandreducedexercisetolerancewhoweretakingdigoxinanddiureticsPatientswererandomizedtodouble-blindtreatmentwithplacebo,prazosin(20mgperday),orthecombinationofhydralazine(30
4、0mgperday)andisosorbidedinitrate(160mgperday)NEnglJMed1986;314:1547-52V-HEFTICumulativeMortalityfromtheTimeofRandomizationintheThreeTreatmentGroupsNEnglJMed1986;314:1547-52V-HEFTIResultsMortalityovertheentirefollow-upperiodwaslowerintheHyd-Isogroup
5、vs.placebo.ThedifferencewasofborderlinestatisticalsignificanceRiskreductionattwoyearsintheHyd-Isogroupwas34%(p=0.028)RiskreductionatthreeyearsintheHyd-Isogroupwas36%MortalityintheprazosingroupwassimilartoplaceboEFrosesignificantlyateightweeksandatone
6、yearintheHyd-Isogroupbutnotintheplaceboorprazosingroups.NEnglJMed1986;314:1547-52V-HEFTIConclusion“Thedatasuggeststhattheadditionofhydralazineandisosorbidenitratetothetherapeuticregimenofdigoxinanddiureticsinpatientswithchroniccongestiveheartfailure
7、canhaveafavorableeffectonleftventricularfunctionandmortality”NEnglJMed1986;314:1547-52
此文档下载收益归作者所有